Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL7592206

O=C(CCCCC1=CC=C2CCCNC2N1)NC[C@H](NS(=O)(=O)c1cccs1)C(=O)O.O=C(O)C(F)(F)F

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 14/20 0.43
ITGA2B P08514 8/20 0.43
ITGAV P06756 8/20 0.41
KMT2A Q03164 1/20 0.34
TSHR P16473 1/20 0.34
ALDH1A1 P00352 3/20 0.33
HTT P42858 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
USP2 O75604 1/20 0.32
GLA P06280 1/20 0.32
PKM P14618 1/20 0.32
HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL7590553 0.89 ITGB3 (0.52) ITGB3ITGA2BITGAV
Trifluoroacetic Acid SCHEMBL6424127 0.77 ITGAV (0.72) ITGB3ITGA2BITGAV
Trifluoroacetic Acid SCHEMBL6424123 0.77 ITGAV (0.72) ITGB3ITGA2BITGAV
Trifluoroacetic Acid SCHEMBL7590565 0.74 ITGB3 (0.38) ITGB3ITGA2BITGAVALDH1A1
SCHEMBL7596092 0.74 ITGB3 (0.54) ITGB3ITGA2BITGAV
SCHEMBL7578474 0.70 ITGB3 (0.46) ITGB3ITGA2BITGAVKMT2ATSHR
Trifluoroacetic Acid SCHEMBL7592202 0.69 ITGB3 (0.42) ITGB3ITGA2BITGAVKMT2ATSHR
Hydrochloric Acid SCHEMBL7594982 0.67 ITGAV (0.53) ITGB3ITGAV
SCHEMBL6424128 0.67 ITGB3 (0.61) ITGB3ITGAV
Trifluoroacetic Acid SCHEMBL7654076 0.66 SLC1A3 (0.54) ITGB3ITGA2BKMT2ATSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1040098-A1 INTEGRIN RECEPTOR ANTAGONISTS Merck & Co., Inc. (a New Jersey corp.) (US) 2000-10-04 EP claimed
WO-1999031061-A1 INTEGRIN RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1999-06-24 WO claimed